Source comparison
MOTS-c vs 5-Amino-1MQ FAQs
MOTS-c is a mitochondrial-derived peptide that activates AMPK to regulate glucose uptake and fat oxidation. 5-Amino-1MQ is a small-molecule NNMT inhibitor that increases NAD⁺ levels to shift fat cell metabolism. They target different enzymes and pathways but b
This comparison does not assign a generated winner or score.
- MOTS-c is a mitochondrial-derived peptide that activates AMPK to regulate glucose uptake and fat oxidation. 5-Amino-1MQ is a small-molecule NNMT inhibitor that increases NAD⁺ levels to shift fat cell metabolism. They target different enzymes and pathways but both aim at metabolic improvement.
- Both show preclinical promise through different mechanisms. MOTS-c has stronger data on overall metabolic regulation and exercise capacity via AMPK. 5-Amino-1MQ directly targets fat cell metabolism through NNMT inhibition and NAD⁺ elevation. Neither has robust human clinical trial data yet.
- 5-Amino-1MQ is orally bioavailable and typically supplied as capsules, making it one of the few metabolic research compounds that does not require injection. MOTS-c is administered via subcutaneous injection like most research peptides, as it requires parenteral delivery for bioavailability.
- Some researchers include both in metabolic stacks because their mechanisms do not overlap — AMPK activation and NNMT inhibition are independent pathways. However, no published studies have evaluated this specific combination, and both compounds remain in early research stages with limited human data.